Literature DB >> 1081895

B lymphocyte subpopulations in chronic lymphocytic leukemia.

R A Rudders.   

Abstract

We have defined two subpopulations of B lymphocytes in chronic lymphocytic leukemia (CLL). The major variant (termed typical) was characterized by the presence of a relatively homogeneous population of small-to-medium-sized lymphocytes with low-density SmIgM and no evidence of intracellular Ig synthesis. A minor group (termed atypical) was identified by the presence of a pleomorphic cell population with few small lymphocytes. The predominant SmIg was IgG, which was detected intracellularly as well as in the serum. The atypical group appeared to be an arrest at a later stage of differentiation where a switch from IgM to IgG synthesis and secretion had occurred. Clinical correlation suggested several clear-cut differences in clinicopathologic characteristics, but the median survivals for both groups at 2 yr was nearly identical.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1081895

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  11 in total

1.  T-cell and B-cell identification in the diagnosis of lymphoproliferative disease. A review.

Authors:  T L Whiteside; D T Rowlands
Journal:  Am J Pathol       Date:  1977-09       Impact factor: 4.307

2.  Biosynthesis and characterization of intracellular IgDkappa in a case of CLL.

Authors:  J Gordon; J L Smith; D Newell; M Chisholm; G Corte; A Warley; N Richardson
Journal:  Clin Exp Immunol       Date:  1977-10       Impact factor: 4.330

3.  Expression of immunoglobin G on blood lymphocytes in chronic lymphocytic leukaemia.

Authors:  H S Dhaliwal; N R Ling; S Bishop; H Chapel
Journal:  Clin Exp Immunol       Date:  1978-02       Impact factor: 4.330

4.  Morphology of lymphatic cells and of their derived tumours.

Authors:  F Rilke; S Pilotti; A Carbone; L Lombardi
Journal:  J Clin Pathol       Date:  1978-11       Impact factor: 3.411

5.  Receptors for Helix pomatia A haemagglutinin on leukaemic lymphocytes from patients with chronic lymphocytic leukaemia (CLL).

Authors:  U Hellstrom; H Mellstedt; P Perlmann; G Holm; D PETTERSSON
Journal:  Clin Exp Immunol       Date:  1976-11       Impact factor: 4.330

6.  T lymphocytes bearing complement receptors in a patient with chronic lymphocytic leukaemia.

Authors:  H R Toben; R G Smith
Journal:  Clin Exp Immunol       Date:  1977-02       Impact factor: 4.330

7.  Structure and biological functions of human IgD. XII. Anti-IgD enhancement of PHA responsiveness in patients with chronic lymphocytic leukaemia.

Authors:  V Kermani-Arab; G A Leslie; D R Burger
Journal:  Clin Exp Immunol       Date:  1977-12       Impact factor: 4.330

8.  Characterization of chronic lymphocytic leukemia (CLL) cells with low density of surface membrane bound immunoglobulins (smIg).

Authors:  E Kimby; B Axelsson; M Björkholm; J Gordon; G Holm; H Mellstedt
Journal:  Med Oncol Tumor Pharmacother       Date:  1985

9.  Free light chain synthesis by neoplastic cells in chronic lymphocytic leukaemia and non-Hodgkin's lymphoma.

Authors:  J Gordon; A R Howlett; J L Smith
Journal:  Immunology       Date:  1978-03       Impact factor: 7.397

10.  Evidence for a change in the expression of beta2-microglobulin-assoicated membrane structures on leukaemic human cells.

Authors:  T Plesner; H Karle; B Rubin; M Thomsen
Journal:  Clin Exp Immunol       Date:  1978-02       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.